An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer's disease

European Journal of Neurology

Volumn 15, Issue 8, 2008, Pages 865-868

  Heo, J H ^a   Lee, S T ^b   Chu, K ^b   Oh, M J ^b   Park, H J ^b   Shim, J Y ^b   Kim, M ^b  

^a Seoul Medical Center   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Alzheimer's disease; Cognition; Korean red ginseng

Indexed keywords

DONEPEZIL; GALANTAMINE; GINSENG EXTRACT; MEMANTINE; RIVASTIGMINE;

ADJUVANT THERAPY; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOLLOW UP; GINSENG; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; NEUROPSYCHOLOGICAL TEST; PHYTOTHERAPY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL;

AGED; ALZHEIMER DISEASE; COGNITION DISORDERS; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PANAX; PHYTOTHERAPY; PILOT PROJECTS;

EID: 54549111180     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02157.x     Document Type: Article

References (8)

1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
2. Lee SK, Kim JH, Sohn HJ, Yang JW. Changes in aroma characteristics during the preparation of red ginseng estimated by electronic nose, sensory evaluation and gas chromatography/mass spectrometry. Sensors and Actuators. B, Chemical 2005; 106: 7-12.
3. Ky N. The comparative understanding between red ginseng and white ginsengs, processed ginsengs (Panax ginseng C. A. Meyer). Journal of Ginseng Research 2005; 1: 1-18.
4. Sorensen H, Sonne J. A double masked study of the effects of ginseng on cognitive functions. Current Therapeutic Research 1996; 57: 959-968.
5. Baek NI, Kim DS, Lee YH, Park JD, Lee CB, Kim SI. Ginsenoside Rh4, a genuine dammarane glycoside from Korean red ginseng. Planta Medica 1996; 62: 86-87.
6. Benishin CG, Lee R, Wang LCH, Liu HJ. Effects of gin-senoside Rb1 on central cholinergic metabolism. Pharmacology 1991; 42: 223-229.
7. Tohda C, Matsumoto N, Zou K, Meselhy MR, Komatsu K. Aβ(25-35)- induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, a metabolit of protopanaxadiol-type saponins. Neuropsychopharma-cology 2004; 29: 860-868.
8. Chen F, Eckman EA, Eckman CB. Reductions in levels of the Alzheimer's amyloid beta peptide after oral administration of ginsenosides. FASEB Journal 2006; 20: 1269-1271.